vimarsana.com

உலகளாவிய நிதி மூலோபாயம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Submit Feedback on PEPFAR s Strategy Vision 2025 Draft

Submit Feedback on PEPFAR s Strategy Vision 2025 Draft
gbchealth.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gbchealth.org Daily Mail and Mail on Sunday newspapers.

Global Fund 45th Board Meeting Reports Continued Progress Despite COVID-19 Pandemic - World

After the pandemic: health and multilateralism at work

Gunilla Carlsson, Vice-Chair, Global Fund Strategy Committee Sergio Dompé, President of Dompé Farmaceutici and Chair of the B20 working group on health and life sciences Anthony Dworkin, Research Director and Senior Policy Fellow, ECFR Chaired by Alessandro Speciale, Rome Bureau Chief, Bloomberg The covid-19 pandemic has highlighted the vulnerabilities of an interconnected world, but it has also created a new sense of urgency behind the need for multilateral action, which has been shown to be directly connected to the health and well-being of individuals in every country.

Global Fund 45th Board Meeting Reports Continued Progress Despite COVID-19 Pandemic

12 May 2021 GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria overwhelmingly praised the continued progress of the Global Fund in the past year despite the challenges of the COVID-19 pandemic. The Board discussed how the Global Fund partnership can continue to support countries to respond to COVID-19 and prepare for future pandemics, while at the same time mitigating the impact on HIV, TB and malaria programs and strengthen systems for health in order to reach the target of ending HIV, TB and malaria as epidemics by 2030. “Our mission to end HIV, TB and malaria as epidemics by 2030 is as relevant as it was 20 years ago. It is only the context and environment around us that has shifted beyond measure, and we have to adjust,” said Dr. Donald Kaberuka, Board Chair.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.